Как кетогенная диета может укрепить гематоэнцефалический барьер и сделать его более устойчивым?
23 января 2024
В этой статье мы обсудим, что такое гематоэнцефалический барьер, какие симптомы могут возникнуть при его повреждении и нарушении герметичности и какие лабораторные тесты можно провести, чтобы определить, насколько он герметичен.
! Carnevale, R., Pastori, D., Nocella, C., Cammisotto, V., Baratta, F., Del Ben, M., Angelico, F., Sciarretta, S., Bartimoccia, S., Novo, M., Targher, G., & Violi, F. (2017). Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose. Nutrition, Metabolism and Cardiovascular Diseases, 27(10), 890–895. https://doi.org/10.1016/j.numecd.2017.06.007
Cheng, S., Chen, G.-Q., Leski, M., Zou, B., Wang, Y., & Wu, Q. (2006). The effect of d,l-β-hydroxybutyric acid on cell death and proliferation in L929 cells. Biomaterials, 27(20), 3758–3765. https://doi.org/10.1016/j.biomaterials.2006.02.046
Chiry, O., Fishbein, W. N., Merezhinskaya, N., Clarke, S., Galuske, R., Magistretti, P. J., & Pellerin, L. (2008). Distribution of the monocarboxylate transporter MCT2 in human cerebral cortex: An immunohistochemical study. Brain Research, 1226, 61–69. https://doi.org/10.1016/j.brainres.2008.06.025
Chiry, O., Pellerin, L., Monnet-Tschudi, F., Fishbein, W. N., Merezhinskaya, N., Magistretti, P. J., & Clarke, S. (2006). Expression of the monocarboxylate transporter MCT1 in the adult human brain cortex. Brain Research, 1070(1), 65–70. https://doi.org/10.1016/j.brainres.2005.11.064
Choquet, D., & Triller, A. (2013). The Dynamic Synapse. Neuron, 80(3), 691–703. https://doi.org/10.1016/j.neuron.2013.10.013
Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., & Janigro, D. (2011). The role of shear stress in Blood-Brain Barrier endothelial physiology. BMC Neuroscience, 12(1), 40. https://doi.org/10.1186/1471-2202-12-40
Cummins, P. M. (2011). Occludin: one Protein. Many Forms. Mol. Cell. Biol. 32, 242–250. doi: 10.1128/mcb.06029-11
Damir Janigro. (n.d.). IJMS | Free Full-Text | Ketone Bodies Promote Amyloid-β1–40 Clearance in a Human in Vitro Blood–Brain Barrier Model. Retrieved June 5, 2022, from https://www.mdpi.com/1422-0067/21/3/934
Damir Janigro. (2022). Effects of the Ketogenic Diet on the Blood-Brain Barrier. In Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease (2nd ed., pp. 346–363). Oxford University Press.
Datis Kharrazian. (2020, July 23). Leaky Brain: Brain fog, memory loss, depression. https://www.youtube.com/watch?v=ulj5wuGajFw
Fasano, A. (2020). All disease begins in the (leaky) gut: Role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research, 9, F1000 Faculty Rev-69. https://doi.org/10.12688/f1000research.20510.1
FoundMyFitness. (2022, May 31). Intestinal Permeability: The Bacterial link to Aging, Brain Barrier Dysfunction & Metabolic Disorder. https://www.youtube.com/watch?v=evQAzGaW1JU
Frontiers | Neurological Symptoms of COVID-19: The Zonulin Hypothesis | Immunology. (n.d.). Retrieved May 22, 2022, from https://www.frontiersin.org/articles/10.3389/fimmu.2021.665300/full
Gibson, C. L., Murphy, A. N., & Murphy, S. P. (2012). Stroke outcome in the ketogenic state – a systematic review of the animal data. Journal of Neurochemistry, 123(s2), 52–57. https://doi.org/10.1111/j.1471-4159.2012.07943.x
Glial Fibrillary Acidic Protein—An overview | ScienceDirect Topics. (n.d.). Retrieved May 22, 2022, from https://www.sciencedirect.com/topics/neuroscience/glial-fibrillary-acidic-protein
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020). Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases. International Journal of Molecular Sciences, 21(22), 8767. https://doi.org/10.3390/ijms21228767
Kadry, H., Noorani, B., Bickel, U., Abbruscato, T. J., & Cucullo, L. (2021). Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: A quantitative evaluation of the protective effects of metformin using small-molecular-weight paracellular markers. Fluids and Barriers of the CNS, 18(1), 28. https://doi.org/10.1186/s12987-021-00261-4
Kakaroubas, N., Brennan, S., Keon, M., & Saksena, N. K. (2019). Pathomechanisms of Blood-Brain Barrier Disruption in ALS. Neuroscience Journal, 2019, e2537698. https://doi.org/10.1155/2019/2537698
Llorens, S., Nava, E., Muñoz-López, M., Sánchez-Larsen, Á., & Segura, T. (2021). Neurological Symptoms of COVID-19: The Zonulin Hypothesis. Frontiers in Immunology, 12. https://www.frontiersin.org/article/10.3389/fimmu.2021.665300
Masino, S. A. (2022). Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease. Oxford University Press.
Masino, S. A., & Rho, J. M. (2012). Mechanisms of Ketogenic Diet Action. In J. L. Noebels, M. Avoli, M. A. Rogawski, R. W. Olsen, & A. V. Delgado-Escueta (Eds.), Jasper’s Basic Mechanisms of the Epilepsies (4th ed.). National Center for Biotechnology Information (US). http://www.ncbi.nlm.nih.gov/books/NBK98219/
Morris, G., Fernandes, B. S., Puri, B. K., Walker, A. J., Carvalho, A. F., & Berk, M. (2018). Leaky brain in neurological and psychiatric disorders: Drivers and consequences. Australian & New Zealand Journal of Psychiatry, 52(10), 924–948. https://doi.org/10.1177/0004867418796955
Olung, N. F., Aluko, O. M., Jeje, S. O., Adeagbo, A. S., & Ijomone, O. M. (2021). Vascular Dysfunction in the Brain; Implications for Heavy Metal Exposures. Current Hypertension Reviews, 17(1), 5–13. https://doi.org/10.2174/1573402117666210225085528
Rahman, M. T., Ghosh, C., Hossain, M., Linfield, D., Rezaee, F., Janigro, D., Marchi, N., & van Boxel-Dezaire, A. H. H. (2018). IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases. Biochemical and Biophysical Research Communications, 507(1), 274–279. https://doi.org/10.1016/j.bbrc.2018.11.021
Reports | Free Full-Text | Gluten Ataxia Associated with Dietary Protein Cross-Reactivity with GAD-65. (n.d.). Retrieved May 22, 2022, from https://www.mdpi.com/2571-841X/3/3/24
Rhea, E. M., & Banks, W. A. (2019). Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance. Frontiers in Neuroscience, 13. https://www.frontiersin.org/article/10.3389/fnins.2019.00521
Rose, J., Brian, C., Pappa, A., Panayiotidis, M. I., & Franco, R. (2020). Mitochondrial Metabolism in Astrocytes Regulates Brain Bioenergetics, Neurotransmission and Redox Balance. Frontiers in Neuroscience, 14. https://www.frontiersin.org/article/10.3389/fnins.2020.536682
Takahashi, S. (2020). Metabolic compartmentalization between astroglia and neurons in physiological and pathophysiological conditions of the neurovascular unit. Neuropathology, 40(2), 121–137. https://doi.org/10.1111/neup.12639
Vojdani, A., Vojdani, E., & Kharrazian, D. (2017). Fluctuation of zonulin levels in blood vs stability of antibodies. World Journal of Gastroenterology, 23(31), 5669–5679. https://doi.org/10.3748/wjg.v23.i31.5669
Xiao M, Xiao ZJ, Yang B, Lan Z and Fang F (2020) Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders. Front. Neurosci. 14:764. doi: 10.3389/fnins.2020.00764
Xylaki, M., Atzler, B., & Outeiro, T. F. (2019). Epigenetics of the Synapse in Neurodegeneration. Current Neurology and Neuroscience Reports, 19(10), 72. https://doi.org/10.1007/s11910-019-0995-y
Yang, Z., & Wang, K. K. W. (2015). Glial Fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker. Trends in Neurosciences, 38(6), 364–374. https://doi.org/10.1016/j.tins.2015.04.003
Zekeridou, A., & Lennon, V. A. (2015). Aquaporin-4 autoimmunity. Neurology – Neuroimmunology Neuroinflammation, 2(4). https://doi.org/10.1212/NXI.0000000000000110
Zheng, W., & Ghersi-Egea, J.-F. (2020). ToxPoint: Brain Barrier Systems Play No Small Roles in Toxicant-induced Brain Disorders. Toxicological Sciences, 175(2), 147–148. https://doi.org/10.1093/toxsci/kfaa053
